Davis P L, Lee S K, Johnson M A. "一种的合成方法" [P]. US Patent, US 11892871 B2, 2017-12-15.
Fischer A B, Klinger H, Kumar R. "Method for the Synthesis of Ethyl 5-{1,4-dioxo-octahydropyrrolo-[1,2-c]pyrimidin-2-yl}pentanoate" [P]. US Patent, US 11843084 B2, 2016-04-26.
Williams B T, Fischer A B, O'Brien P Q. "A Process for Preparing High-Purity Ethyl 5-{1,4-dioxo-octahydropyrrolo-[1,2-c]pyrimidin-2-yl}pentanoate" [P]. US Patent, US 11141228 B2, 2021-01-07.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2019, 1827, (3), 2841-2860.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2020, 538, 2128-2131.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 5-{1,4-dioxo-octahydropyrrolo-[1,2-c]pyrimidin-2-yl}pentanoate Using HRMS and NMR". J. Pharm. Biomed. Anal., 2011, 2411, (1), 9337-9357.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2017, 468, (9), 5604-5631.